ArticleLancet (London, England)2021
Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.BMC public health · 2023Pooled it
- Evaluation of the exit screening policy among travelers arriving from Asian and pacific nations.BMC infectious diseases · 2024Article
- Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study.The Lancet regional health. Western Pacific · 2024Article
- Governance, policy, and health systems responses to the COVID-19 pandemic in Thailand: a qualitative study.Frontiers in public health · 2024Article
- High connectivity and human movement limits the impact of travel time on infectious disease transmission.Journal of the Royal Society, Interface · 2024Article
- Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China.Frontiers in public health · 2024Article
- The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.PloS one · 2024Article
- Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2023Article
- Article
- Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing.PNAS nexus · 2022Article
- Asia Pacific perspectives on the second year of the COVID-19 pandemic: A follow-up survey.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022Article
- Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.Microbiology spectrum · 2022Article
- Impact of Vaccine and Immunity Passports in the Context of COVID-19: A Time Series Analysis in Overseas France.Vaccines · 2022Article
- Mental Health Outcomes in Australian Healthcare and Aged-Care Workers during the Second Year of the COVID-19 Pandemic.International journal of environmental research and public health · 2022Article
- "Well, I Signed Up to Be a Soldier; I Have Been Trained and Equipped Well": Exploring Healthcare Workers' Experiences during COVID-19 Organizational Changes in Singapore, from the First Wave to the Path towards Endemicity.International journal of environmental research and public health · 2022Article
- Genomic epidemiology of SARS-CoV-2 under an elimination strategy in Hong Kong.Nature communications · 2022Article
- How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.BMJ global health · 2022Article
- A multidisciplinary effort to increase COVID-19 vaccination among the older adults.Frontiers in public health · 2022Article
- On Coexistence with COVID-19: Estimations and Perspectives.China CDC weekly · 2021Article
- Aggressive containment, suppression, and mitigation of covid-19: lessons learnt from eight countries.BMJ (Clinical research ed.) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.